BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 6213815)

  • 1. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin.
    Rosenzweig LJ; Kanwar YS
    Lab Invest; 1982 Aug; 47(2):177-84. PubMed ID: 6213815
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of de novo synthesized sulfated glycosaminoglycans in the glomerular basement membrane and mesangial matrix.
    Kanwar YS; Rosenzweig LJ; Jakubowski ML
    Lab Invest; 1983 Aug; 49(2):216-25. PubMed ID: 6410121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.
    Wijnhoven TJ; Lensen JF; Wismans RG; Lefeber DJ; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
    J Am Soc Nephrol; 2007 Dec; 18(12):3119-27. PubMed ID: 18003778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.
    Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM
    N Engl J Med; 1983 Oct; 309(17):1001-9. PubMed ID: 6225948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of glycosaminoglycans from bovine granulosa cells contributes to increased binding of hydrogen-3 heparin.
    Ax RL; Stodd CM; Boehm SK; Bellin ME
    J Dairy Sci; 1986 Feb; 69(2):531-4. PubMed ID: 3700794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
    Garin EH; Shirey AJ
    Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
    Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
    Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion.
    Kanwar YS; Linker A; Farquhar MG
    J Cell Biol; 1980 Aug; 86(2):688-93. PubMed ID: 6447156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of immune complexes with glomerular heparan sulfate-proteoglycans.
    Kanwar YS; Caulin-Glaser T; Gallo GR; Lamm ME
    Kidney Int; 1986 Dec; 30(6):842-51. PubMed ID: 2950267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
    Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
    J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic epithelial cells synthesize a heparan sulfate with a highly sulfated region.
    Werneck CC; Oliveira-Dos-Santos AJ; Silva LC; Villa-Verde DM; Savino W; MourĂ£o PA
    J Cell Physiol; 1999 Jan; 178(1):51-62. PubMed ID: 9886490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans of the glomerular basement membrane in normal and nephrotic states.
    Kanwar YS; Rosenzweig LJ; Kerjaschki DI
    Ren Physiol; 1981; 4(2-3):121-30. PubMed ID: 7302362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking down the barrier: evidence against a role for heparan sulfate in glomerular permselectivity.
    Harvey SJ; Miner JH
    J Am Soc Nephrol; 2007 Mar; 18(3):672-4. PubMed ID: 17301187
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial ischemia and proteinuria during isolated kidney perfusion is accompanied by the release of vascular [35S]heparan sulfate.
    Vassiliou P; Tay M; Comper WD
    Biochem Int; 1989 Dec; 19(6):1241-51. PubMed ID: 2534569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes.
    Jeansson M; Haraldsson B
    J Am Soc Nephrol; 2003 Jul; 14(7):1756-65. PubMed ID: 12819235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
    van den Born J; Berden JH
    Nephrol Dial Transplant; 1995; 10(8):1277-9. PubMed ID: 8538909
    [No Abstract]   [Full Text] [Related]  

  • 17. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
    Hallak LK; Collins PL; Knudson W; Peeples ME
    Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding.
    Chen LD; Hazlett LD
    Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of heparan sulfate isolated from drug glomerular basement membranes.
    Linker A; Hovingh P; Kanwar YS; Farquhar MG
    Lab Invest; 1981 Jun; 44(6):560-5. PubMed ID: 6453253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity binding of interferon-gamma to a basement membrane complex (matrigel).
    Lortat-Jacob H; Kleinman HK; Grimaud JA
    J Clin Invest; 1991 Mar; 87(3):878-83. PubMed ID: 1900310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.